Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Raw Materials (2020 - 2026)

SkinHealth Systems has reported Raw Materials over the past 6 years, most recently at $18.5 million for Q4 2025.

  • Quarterly Raw Materials fell 28.72% to $18.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Dec 2025, down 28.72% year-over-year, with the annual reading at $18.5 million for FY2025, 28.72% down from the prior year.
  • Raw Materials was $18.5 million for Q4 2025 at SkinHealth Systems, down from $23.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $40.0 million in Q1 2023 and troughed at $11.7 million in Q3 2021.
  • The 5-year median for Raw Materials is $23.8 million (2023), against an average of $24.0 million.
  • Year-over-year, Raw Materials skyrocketed 219.14% in 2022 and then crashed 40.57% in 2024.
  • A 5-year view of Raw Materials shows it stood at $12.0 million in 2021, then skyrocketed by 219.14% to $38.4 million in 2022, then crashed by 36.4% to $24.4 million in 2023, then grew by 6.61% to $26.0 million in 2024, then fell by 28.72% to $18.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Raw Materials are $18.5 million (Q4 2025), $23.0 million (Q3 2025), and $23.0 million (Q2 2025).